About Rottapharm Biotech
Rottapharm Biotech is a company based in Monza (Italy) founded in 2014. It operates as a B2B. Rottapharm Biotech offers products and services including Vorbipiprant and CR10049. Rottapharm Biotech operates in a competitive market with competitors including Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
- Headquarter Monza, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Rottapharm Biotech S.R.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rottapharm Biotech
Rottapharm Biotech offers a comprehensive portfolio of products and services, including Vorbipiprant and CR10049.
Therapeutic for treating colorectal cancer in clinical trials
Potential treatment for inflammatory osteoarthritis conditions
Funding Insights of Rottapharm Biotech
Detailed funding history for Rottapharm Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rottapharm Biotech
Investment portfolio details for Rottapharm Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rottapharm Biotech
Detailed financials for Rottapharm Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rottapharm Biotech Comparisons
Peer comparison for Rottapharm Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rottapharm Biotech
Rottapharm Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, UCB, Grifols, Kymeratx and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for immunological and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Plasma-derived therapies are developed to treat multiple diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
Detailed competitors of Rottapharm Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rottapharm Biotech
Complete news archive for Rottapharm Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rottapharm Biotech
Rottapharm Biotech was founded in 2014.
Rottapharm Biotech is headquartered in Monza, Italy. It is registered at Monza, Lombardy, Italy.
Rottapharm Biotech is a biotechnology company dedicated to discovering and developing novel drugs for therapeutic areas like oncology and inflammatory diseases. They operate through internal product development and external partnerships, including strategic investments and collaborations. Based in Monza, Italy, as part of the Fidim Group, they focus on innovation in drug research without specifying direct clients.
Rottapharm Biotech's top competitors include ADMA Biologics, BioNTech and Generate Biomedicines.
Rottapharm Biotech offers Vorbipiprant and CR10049.